Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course

by Claudio Liguori, Fabio Placidi, Francesca Izzi, Matteo Spanetta, Nicola Biagio Mercuri, Alessandra Di Pucchio
Published 2020-01-01

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease

by Elena Carapelle, Ciro Mundi, Tommaso Cassano, Carlo Avolio
Published 2020-08-01

Frontal presentation of Alzheimer's disease: A series of patients with biological evidence by CSF biomarkers

by Leonardo Cruz de Souza, Maxime Bertoux, Aurélie Funkiewiez, Dalila Samri, Carole Azuar, Marie-Odile Habert, Aurélie Kas, Foudil Lamari, Marie Sarazin, Bruno Dubois

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease

by Julien Dumurgier, Audrey Gabelle, Olivier Vercruysse, Stéphanie Bombois, Jean-Louis Laplanche, Katell Peoc'h, Susanna Schraen, Bernard Sablonnière, Florence Pasquier, Jacques Touchon, Sylvain Lehmann, Jacques Hugon, Claire Paquet
Published 2013-06-01

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease

by Linda P. Oosterveld, Tessa I. Kuiper, Nour K. Majbour, Inge M. W. Verberk, Karin D. van Dijk, Jos W. R. Twisk, Omar M. El-Agnaf, Charlotte E. Teunissen, Henry C. Weinstein, Martin Klein, Henk W. Berendse, Wilma D. J. van de Berg
Published 2020-11-01

Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

by Giulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, Matteo Casini, Sonia Padiglioni, Cristina Polito, Valentina Berti, Juri Balestrini, Camilla Ferrari, Gemma Lombardi, Assunta Ingannato, Sandro Sorbi, Benedetta Nacmias, Valentina Bessi
Published 2021-01-01

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

by Adla Boumenir, Emmanuel Cognat, Severine Sabia, Claire Hourregue, Matthieu Lilamand, Aline Dugravot, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Jacques Hugon, Archana Singh-Manoux, Claire Paquet, Julien Dumurgier
Published 2019-03-01

Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

by Steffen Wolfsgruber, José Luis Molinuevo, Michael Wagner, Charlotte E. Teunissen, Lorena Rami, Nina Coll-Padrós, Femke H. Bouwman, Rosalinde E. R. Slot, Linda M. P. Wesselman, Oliver Peters, Katja Luther, Katharina Buerger, Josef Priller, Christoph Laske, Stefan Teipel, Annika Spottke, Michael T. Heneka, Emrah Düzel, Alexander Drzezga, Jens Wiltfang, Sietske A. M. Sikkes, Wiesje M. van der Flier, Frank Jessen, on behalf of the Euro-SCD working group
Published 2019-01-01

Quantification of Two Fluorophores’ Concentration Ratio in a Mice Model in Preparation for a Proposed Method for Early Detection of Alzheimer’s Disease

by Osnat Harbater, Margalit Efrati, Israel Gannot
Published 2018-05-01

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease

by Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, Renata Borawska, Barbara Mroczko
Published 2021-07-01

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease

by Lena L. Law, Rachael N. Rol, Stephanie A. Schultz, Ryan J. Dougherty, Dorothy F. Edwards, Rebecca L. Koscik, Catherine L. Gallagher, Cynthia M. Carlsson, Barbara B. Bendlin, Henrik Zetterberg, Kaj Blennow, Sanjay Asthana, Mark A. Sager, Bruce P. Hermann, Sterling C. Johnson, Dane B. Cook, Ozioma C. Okonkwo
Published 2018-01-01

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

by Melinda Rezeli, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Thomas Laurell, Oskar Hansson, György Marko-Varga
Published 2015-09-01

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau

by Kristi Henjum, Else Quist-Paulsen, Henrik Zetterberg, Kaj Blennow, Lars N. G. Nilsson, Leiv Otto Watne
Published 2018-11-01

Biomarker-based prediction of progression in MCI: Comparison of AD-signature and hippocampal volume with spinal fluid amyloid-β and tau

by Bradford C Dickerson, David eWolk
Published 2013-10-01

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

by Flora H. Duits, Gunnar Brinkmalm, Charlotte E. Teunissen, Ann Brinkmalm, Philip Scheltens, Wiesje M. Van der Flier, Henrik Zetterberg, Kaj Blennow
Published 2018-01-01

A/T/(N) Profile in Cerebrospinal Fluid of Parkinson’s Disease with/without Cognitive Impairment and Dementia with Lewy Bodies

by Giovanni Bellomo, Federico Paolini Paoletti, Elena Chipi, Maya Petricciuolo, Simone Simoni, Nicola Tambasco, Lucilla Parnetti
Published 2020-11-01

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?

by Victor Bloniecki, Henrik Zetterberg, Dag Aarsland, Patrizia Vannini, Hlin Kvartsberg, Bengt Winblad, Kaj Blennow, Yvonne Freund-Levi
Published 2020-11-01

Genetic Variation Modifies Risk for Neurodegeneration Based on Biomarker Status

by Timothy J Hohman, Mary Ellen I Koran, Tricia Ann Thornton-Wells
Published 2014-08-01

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease

by V. Velickaite, V. Giedraitis, K. Ström, I. Alafuzoff, H. Zetterberg, L. Lannfelt, L. Kilander, E-M. Larsson, M. Ingelsson
Published 2017-09-01

Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study

by Da-Wei Li, Da-Wei Li, Haitao Ren, Andreas Jeromin, Mingsheng Liu, Dongshao Shen, Hongfei Tai, Qingyun Ding, Xiaoguang Li, Liying Cui, Liying Cui
Published 2018-08-01